Hk Inno.n Corporation

This study tests an experimental injection called IN-B00009 for weight loss in adults with obesity or overweight who do not have diabetes. About 300 participants will receive either the drug or a placebo for 40 weeks. The main goals are to see how much weight people lose and how …

This study tests an experimental injection called IN-B00009 in adults with type 2 diabetes whose blood sugar is not well managed by diet and exercise alone. About 110 participants will receive either the drug or a placebo for 24 weeks. The main goal is to see if the drug lowers H…

This study checks whether two versions of a drug (IN-M00007 and IN-R00007) are absorbed into the body the same way. About 60 healthy adults aged 19 to 59 will take a single dose of each drug at different times. The goal is to compare safety and drug levels in the blood, not to tr…

This study looks at how a new tablet (IN-M00002) moves through the body when taken alone or with other drugs (tegoprazan and naproxen), and how food affects it. It involves 74 healthy adults aged 19 to 55. The goal is to gather safety and drug-level information, not to treat any …